COVID-19 drug discovery and treatment options
Nature Reviews Microbiology,
Год журнала:
2024,
Номер
22(7), С. 391 - 407
Опубликована: Апрель 15, 2024
Язык: Английский
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Окт. 9, 2024
SARS-CoV-2
JN.1
with
an
additional
L455S
mutation
on
spike
when
compared
its
parental
variant
BA.2.86
has
outcompeted
all
earlier
variants
to
become
the
dominant
circulating
variant.
Recent
studies
investigated
immune
resistance
of
but
factors
are
speculated
contribute
global
dominance,
which
remain
elusive
until
today.
Here,
we
find
that
a
higher
infectivity
than
in
differentiated
primary
human
nasal
epithelial
cells
(hNECs).
Mechanistically,
demonstrate
gained
over
associates
increased
entry
efficiency
conferred
by
and
better
cleavage
hNECs.
Structurally,
S455
altered
mode
binding
protein
ACE2
at
Язык: Английский
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 7, 2024
Abstract
Monoclonal
antibody
(mAb)
therapeutics
hold
promise
for
both
preventing
and
treating
infectious
diseases,
especially
among
vulnerable
populations.
However,
the
emergence
of
various
variants
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
presents
challenges
current
mAb
treatments,
emphasizing
need
more
potent
broadly
neutralizing
antibodies.
In
this
study,
we
employed
an
unbiased
screening
approach
to
discover
antibodies
successfully
isolated
two
mAbs
from
individuals
with
only
exposure
ancestral
SARS-CoV-2.
One
these
antibodies,
CYFN1006-1,
exhibited
robust
cross-neutralization
against
a
spectrum
SARS-CoV-2
variants,
including
latest
JN.1
KP.2
consistent
IC
50
values
ranging
∼1
5
ng/mL.
Notably,
it
also
displayed
broad
neutralization
activity
SARS-CoV
related
sarbecoviruses,
such
as
WIV1,
SHC014,
RaTG13,
GD-Pangolin.
Structural
analysis
revealed
that
target
shared
hotspot
but
mutation-resistant
epitopes,
their
Fabs
locking
RBD
in
“down”
conformation
through
interactions
adjacent
RBDs,
cross-linking
Spike
trimers
into
di-trimers
block
viral
infection.
vivo
studies
conducted
JN.1-infected
hamster
model
validated
protective
efficacy
its
therapeutic
potential.
These
findings
suggest
that,
meticulous
approaches,
rare
activities
sarbecoviruses
can
be
identified
exclusively
virus
exposure.
Язык: Английский
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
Communications Biology,
Год журнала:
2025,
Номер
8(1)
Опубликована: Март 6, 2025
The
emergence
of
various
SARS-CoV-2
variants
presents
challenges
for
antibody
therapeutics,
emphasizing
the
need
more
potent
and
broadly
neutralizing
antibodies.
Here,
we
employed
an
unbiased
screening
approach
successfully
isolated
two
antibodies
from
individuals
with
only
exposure
to
ancestral
SARS-CoV-2.
One
these
antibodies,
CYFN1006-1,
exhibited
robust
cross-neutralization
against
a
spectrum
variants,
including
latest
KP.2,
KP.3
XEC,
consistent
IC50
values
ranging
~1
5
ng/mL.
It
also
displayed
broad
neutralization
activity
SARS-CoV
related
sarbecoviruses.
Structural
analysis
revealed
that
target
shared
hotspot
but
mutation-resistant
epitopes,
their
Fabs
locking
receptor
binding
domains
(RBDs)
in
"down"
conformation
through
interactions
adjacent
RBDs,
cross-linking
Spike
trimers
into
di-trimers.
In
vivo
studies
conducted
JN.1-infected
hamster
model
validated
protective
efficacy
CYFN1006-1.
These
findings
suggest
activities
can
be
identified
exclusively
virus
exposure.
Язык: Английский
Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathways
Journal of Medical Virology,
Год журнала:
2024,
Номер
96(2)
Опубликована: Фев. 1, 2024
Abstract
Interferons
(IFNs)
are
critical
for
immune
defense
against
pathogens.
While
type‐I
and
‐III
IFNs
have
been
reported
to
inhibit
SARS‐CoV‐2
replication,
the
antiviral
effect
mechanism
of
type‐II
IFN
remain
largely
unknown.
Here,
we
evaluate
activity
(IFNγ)
using
human
lung
epithelial
cells
(Calu3)
ex
vivo
tissues.
In
this
study,
found
that
IFNγ
suppresses
replication
in
both
Calu3
Moreover,
treatment
does
not
significantly
modulate
expression
entry‐related
factors
induces
a
similar
level
pro‐inflammatory
response
tissues
when
compared
with
IFNβ
treatment.
Mechanistically,
show
overexpression
indoleamine
2,3‐dioxygenase
1
(IDO1),
which
is
most
profoundly
induced
by
IFNγ,
substantially
restricts
ancestral
Alpha
Delta
variants.
Meanwhile,
loss‐of‐function
study
reveals
IDO1
knockdown
restores
restricted
cells.
We
further
l
‐tryptophan,
substrate
IDO1,
partially
rescues
IFNγ‐mediated
inhibitory
on
Collectively,
these
results
suggest
potently
inhibits
through
IDO1‐mediated
response.
Язык: Английский
Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19
Cell & Bioscience,
Год журнала:
2024,
Номер
14(1)
Опубликована: Сен. 6, 2024
Язык: Английский
Characterization of the Pathogenic Features of Multiple SARS-CoV-2 Pandemic Strains in Different Mouse Models
Опубликована: Янв. 1, 2024
Язык: Английский
Development of a Multi-Target Pharmacophore-Based Virtual Screening Agent Against COVID-19
Al-Mustaqbal Journal of Pharmaceutical and Medical Sciences,
Год журнала:
2024,
Номер
2(1)
Опубликована: Май 30, 2024
The
worldwide
outbreak
of
the
COVID-19
pandemic
compelled
scientists
to
develop
new,
highly
effective
therapeutic
approaches
fight
it.
Multitarget
drugs
have
been
proven
be
in
managing
complex
disorders.
But
designing
multitarget
is
a
great
challenge.
In
this
study,
prevent
lack
efficacy
due
viral
mutation
escape,
multi-target
agent
against
virus
was
discovered.
As
crucial
targets,
RNA-dependent
RNA
polymerase
(RdRp),
main
protease
(Mpro),
and
SARS-CoV-2
Nsp15
were
selected.
A
pharmacophore
model
developed
using
native
ligands
chosen
targets.
This
used
screen
ZINC
Drug
Database
for
commercially
available
compounds
having
similar
features
experimentally
tested
drugs.
Pharmacophore-based
virtual
screening
yielded
1331
hits,
which
further
docked
into
binding
sites
selected
proteins
PyRx
AutoDock
Vina.
Evaluation
docking
results
revealed
that
glisoxepide
(Zn
00537804)
has
highest
scores
three
target
proteins.
It
showed
free
energies
-6.8,
-6.2,
-7.8
kcal/mol
towards
Mpro,
Nsp15,
RdRp,
respectively.
According
an
silico
ADME
follows
Lipinski's
rule.
molecular
dynamics
simulation
study
subsequent
investigations
had
good
stability
within
active
promise
as
potential
treatment
still
needs
evaluated
through
experimental
research.
Язык: Английский
Characterization of the Pathogenic Features of Multiple SARS‐CoV‐2 Pandemic Strains in Different Mouse Models
Journal of Medical Virology,
Год журнала:
2024,
Номер
96(11)
Опубликована: Ноя. 1, 2024
ABSTRACT
Elucidating
the
detailed
features
of
emerging
SARS‐CoV‐2
strains
both
in
vitro
and
vivo
is
indispensable
for
development
effective
vaccines
or
drugs
against
viral
infection.
We
thoroughly
characterized
virological
pathogenic
eight
different
pandemic
strains,
from
WT
strain
to
current
circulating
sublineage
EG.5.1,
vivo.
Besides
observed
Vero
E6
cells,
Omicron
variants,
BA.1
exhibited
enhanced
infectious
effects
upper
respiratory
tract
K18
human
angiotensin‐converting
enzyme
(ACE2)
(K18
hACE2)
transgenic
mice.
Both
XBB.1.9.1
EG.5.1
presented
stronger
tropism
brain,
which
could
be
main
reason
increased
lethal
on
In
addition,
pathogenesis
comparisons
among
all
these
viruses
C57BL/6JGpt
mice
indicated
that
variant
two
new
sublineages
possessed
dual
tropisms
mice,
were
further
confirmed
by
subsequent
bioinformatic
analyses
actual
affinity
comparison
between
RBDs
mouse
receptor
ACE2.
Furthermore,
immunocompromised
BKS‐db
found
more
susceptible
compared
revealed
infectivity
was
determined
its
host
immunocompetence.
Thus,
this
study
not
only
contributes
a
systematic
understanding
but
also
provides
insights
combat
potential
future
surges
variants.
Язык: Английский
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 21, 2024
Coronaviruses
have
caused
three
major
endemics
in
the
past
two
decades.
Alarmingly,
recent
identification
of
novel
zoonotic
coronaviruses
that
human
infections
suggests
risk
future
coronavirus
outbreak
by
spillover
infection
from
animal
reservoirs
remains
high
Язык: Английский